Abbott Announces Supply Agreement For Needlestick Prevention Products

Article

ABBOTT PARK, IL-Abbott Laboratories has signed a supply agreement for VanishPoint needlestick prevention products. VanishPoint products use patented automated retraction technology, which reduces exposure to contaminated needles.

Once a drug injection or blood draw is complete, the needle automatically retracts from the patient into the barrel of the device.

These products will become part of Abbott's Needlestick Prevention Systems product line.

Abbott already provides hospitals and healthcare facilities with VanishPoint blood collection tube holders under an 18-month agreement and VanishPoint retractable syringes as part of a two-year contract.

Abbott's products satisfy new OSHA prevention directives and the Needlestick Safety and Prevention Act, which became law November 2000.

Recent Videos
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Kevin Anderson, MBA, BS, CRCST, Senior Manager, Commercial Education Services, Heatlthmark, a Getinge Company
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Related Content